These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35780275)

  • 1. Postoperative tegafur-uracil for stage I lung adenocarcinoma: first real-world data with an exploratory subgroup analysis.
    Miyata R; Hamaji M; Nakakura A; Morita S; Shimazu Y; Ishikawa M; Kayawake H; Menju T; Sakaguchi Y; Sonobe M; Takahashi M; Aoyama A; Sumitomo R; Huang CL; Kono T; Miyahara R; Matsumoto A; Katakura H; Fukada T; Sakai H; Kobayashi M; Okumura N; Date N; Fujinaga T; Miyamoto E; Nakagawa T; Date H
    Surg Today; 2023 Jan; 53(1):135-144. PubMed ID: 35780275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
    Noro R; Honda K; Nagashima K; Motoi N; Kunugi S; Matsubayashi J; Takeuchi S; Shiraishi H; Okano T; Kashiro A; Meng X; Yoshida Y; Watanabe S; Usuda J; Inoue T; Wilber H; Ikeda N; Seike M; Gemma A; Kubota K
    Cancer Sci; 2022 Mar; 113(3):1002-1009. PubMed ID: 34845792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
    Kato H; Ichinose Y; Ohta M; Hata E; Tsubota N; Tada H; Watanabe Y; Wada H; Tsuboi M; Hamajima N; Ohta M;
    N Engl J Med; 2004 Apr; 350(17):1713-21. PubMed ID: 15102997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung.
    Tsuboi M; Hamada C; Kato H; Ohta M
    Chemotherapy; 2017; 62(6):357-360. PubMed ID: 28817813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
    Liang SK; Wu CW; Chang CI; Keng LT; Lee MR; Wang JY; Ko JC; Liao WY; Chen KY; Ho CC; Shih JY; Yu CJ
    Cancer Med; 2023 Sep; 12(17):17993-18004. PubMed ID: 37559409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
    Suehisa H; Toyooka S; Hotta K; Uchida A; Soh J; Fujiwara Y; Matsuo K; Ouchida M; Takata M; Kiura K; Date H
    J Clin Oncol; 2007 Sep; 25(25):3952-7. PubMed ID: 17761979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single-arm, phase 2 study of adjuvant chemotherapy with oral tegafur-uracil for pathologically lymphovascular invasion positive stage IA non-small cell lung cancer: LOGIK0602 study.
    Tsuchiya T; Kamohara R; Muraoka M; Nagayasu T; Saeki S; Takenoyama M; Suzuki M; Inada K; Tokunaga S; Hayashi T; Urabe S; Koga T; Akamine S; Sugio K
    BMC Cancer; 2020 Dec; 20(1):1192. PubMed ID: 33276755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
    Hamada C; Tsuboi M; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
    J Thorac Oncol; 2009 Dec; 4(12):1511-6. PubMed ID: 19875974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective observational study of the efficacy of oral uracil and tegafur plus leucovorin for stage II colon cancer with risk factors for recurrence using propensity score matching (JFMC46-1201).
    Sadahiro S; Sakamoto K; Tsuchiya T; Takahashi T; Ohge H; Sato T; Kondo K; Ogata Y; Baba H; Itabashi M; Ikeda M; Hamada M; Maeda K; Masuko H; Takahashi K; Sakamoto J; Kusano M; Hyodo I; Taguri M; Morita S
    BMC Cancer; 2022 Feb; 22(1):170. PubMed ID: 35168560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
    Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
    Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tegafur-Uracil in Resected Stage IB Lung Adenocarcinoma According to Presence or Absence of Epidermal Growth Factor Receptor Gene Mutation: A Retrospective Cohort Study.
    Aoki M; Miyata R; Kamimura G; Harada Takeda A; Suetsugu T; Mizuno K; Ueda K
    Ann Thorac Cardiovasc Surg; 2024 Jan; 30(1):. PubMed ID: 38105006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uracil-tegafur in early-stage lung cancer.
    Graziano F
    N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15309743
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.
    Soh J; Toyooka S; Okumura N; Nakamura H; Nakata M; Yamashita M; Sakamoto J; Aoe M; Hotta K; Morita S; Date H
    Int J Clin Oncol; 2019 Nov; 24(11):1367-1376. PubMed ID: 31312931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: a prospective multi-institutional study in Japan.
    Eguchi K; Oyama T; Tajima A; Abiko T; Sawafuji M; Horio H; Hashizume T; Matsutani N; Kato R; Nakayama M; Kawamura M; Kobayashi K
    Lung Cancer; 2015 Jan; 87(1):53-8. PubMed ID: 25468199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefit of Uracil-Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer.
    Chen PH; Jhou HJ; Chung CH; Wu YY; Huang TC; Lee CH; Chien WC; Chen JH
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676634
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytomegalovirus colitis in a patient undergoing postoperative adjuvant chemotherapy for lung adenocarcinoma with uracil-tegafur.
    Hayashi H; Komatsu Y; Uchida T; Abe N; Ito K; Hirata K; Matsuda K; Fujinaga A
    J Infect Chemother; 2016 Dec; 22(12):826-829. PubMed ID: 27527253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uracil-tegafur in early-stage lung cancer.
    Altundag O; Altundag K; Gunduz M
    N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15306675
    [No Abstract]   [Full Text] [Related]  

  • 19. Advantage of post-operative oral administration of UFT (tegafur and uracil) for completely resected p-stage I-IIIa non-small cell lung cancer (NSCLC).
    Tanaka F; Miyahara R; Ohtake Y; Yanagihara K; Fukuse T; Hitomi S; Wada H
    Eur J Cardiothorac Surg; 1998 Sep; 14(3):256-62; discussion 263-4. PubMed ID: 9761434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tegafur-uracil-induced pericardial effusion during adjuvant chemotherapy for resected lung adenocarcinoma: A case report.
    Kawamoto N; Okita R; Hayashi M; Okada M; Inokawa H
    Thorac Cancer; 2021 Mar; 12(5):707-710. PubMed ID: 33463035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.